Jazz Pharmaceuticals Iberia S.L.
Health Care · Biotechnology

Jazz Pharmaceuticals Iberia S.L. revenue, results and funding

Jazz Pharmaceuticals Iberia S.L. filed revenue of $4.3B for 2025.

Data updated Nov 19, 2026 · Back to the company report
$4.3BRevenue, 2025
−$356.1MNet income, 2025

Results by year

YearRevenueNet incomeTotal assetsLANG_CR_S_M_TAX_PAIDLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_BUYBACKSLANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_DEBTLANG_CR_S_M_ACQUISITIONS
2025$4.3B−$356.1M$11.7B$121.8M−$272.4M$125M$58.8M$291.1M$782.7M−$430.2M$1.4B$4.3B–
2024$4.1B$560.1M$12B$114.9M−$91.4M$311.4M$38.1M$248M$884M$716.6M$2.4B$6.1B–
2023$3.8B$414.8M$11.4B$177.9M−$119.9M$269.8M$24M$226.8M$849.7M$578.6M$1.5B$5.1B$0
2022$3.7B−$224.1M$10.8B$94.7M−$158.6M$54k$29M$222M$590.5M−$65.5M$881.5M$5.7B$0
2021$3.1B−$329.7M$12.3B$271.2M$216.1M$0$27.6M$189M$505.7M$170.3M$591.4M$6B$6.2B
2020$2.4B$238.6M$6.5B$226.8M$33.5M$146.5M$15M$121M$335.4M$378.1M$1.1B$1.8B$0
2019$2.2B$523.4M$5.5B$183.6M−$73.2M$301.5M$40.1M$110.6M$299.7M$532.4M$637.3M$1.6B$0
2018$1.9B$447.1M$5.2B$164.2M$80.2M$523.7M$20.4M$102.4M$226.6M$614.8M$309.6M$1.6B$0
2017$1.6B$487.8M$5.1B$174.1M−$47.7M$98.8M$29M$106.9M$198.4M$528.8M$386M$1.5B$0
2016$1.5B$396.8M$4.8B$160.3M$135.2M$278.3M$9.7M$98.8M$162.3M$591.7M$366M$2B$1.5B
2015$1.3B$329.5M$3.3B$145.6M$106.4M$61.6M$36M$91.6M$135.3M$508.2M$988.8M$1.2B$0
2014$1.2B$58.4M$3.3B$108.2M$94.2M$42.2M$36.3M$69.6M$85.2M$195.6M$684M$1.3B$828.7M
2013$872.4M$216.3M$2.2B$137.6M$91.6M$136.5M$10M$44.6M$41.6M$340.3M$636.5M$544.4M$0
2012$586M$288.6M$2B$9.1M−$83.8M$0$6M$23M$20.5M$197.8M$387.2M$427.1M$542.5M
2011$272.3M$125M$253.6M$0$0$0$1.3M$20.7M$14.1M$127.8M$82.1M$0$0
Sources: SEC

How to cite

Jazz Pharmaceuticals Iberia S.L., Financials. Alion, Nov 19, 2026. https://alion.io/company/jazzpharma/financials

.json · .md · CC BY-SA 4.0